Clinical Trials List
2024-10-01 - 2032-12-31
Phase I/II
Recruiting3
ICD-10C16.9
Malignant neoplasm of stomach, unspecified
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.9
Malignant neoplasm of stomach, unspecified
-
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/16
Investigators and Locations
Co-Principal Investigator
- 唐振育 無
- Yi-Ping Hung 無
- Hao-Wei Teng 無
- 姜乃榕 無
- 邱乃祈 無
- San-Chi Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 劉奕廷 無
- 邱彥程 無
- Chiu Hung Chiu 無
- Chih-Chieh Yen 無
- Yu-Min Yeh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
9 participants
-
Global
180 participants
